Skip to content

A study to assess the effectiveness of shock therapy among patients of schizophrenia who are poorly responsive to antipsychotic medications.

Short term efficacy of electroconvulsive therapy in treatment resistant schizophrenia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2011/08/001960
Enrollment
30
Registered
2011-08-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Schizophrenia Health Condition 2: F20- Schizophrenia

Interventions

Intervention1: ELECTROCONVULSIVE THERAPY: 1. ECT machine used was microprocessor brief pulse constant current ECT 2. Bilateral temporal electrode placement 3. ECTs were given twice a week 4. Total num

Sponsors

Government Medical College and Hospital Chandigarh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients in the age group of 16 to 65 years. 2. Patients suffering from schizophrenia as per ICD 10. 3. Patients who fulfilled the criteria for TRS. For the purpose of the study, TRS was defined according to the modified Kane et.al. criteria, which defines TRS as: a) At least two prior drug trials of at least 4-6 weeks duration at 400-600 mg of chlorpromazine (or equivalent) without significant clinical improvement. b) Persistent psychotic symptoms defined as a score of 45 on 18 item scale of BPRS and score of 4 (moderate) on at least two items of positive symptoms. c) The duration of illness should be at least one year. 4. Patients who were accompanied by reliable informants. 5. Patients and informants who were willing to participate in the study and who were ready to give consent for ECT and anesthesia.

Exclusion criteria

Exclusion criteria: 1. Patients who had associated medical problems, which could affect the course of illness as well as their fitness for general anesthesia. 2. Patients of co-morbid substance dependence except nicotine dependence. 3. Patients who had received ECT in the past one-year. 4. Patients who had received at least 4 ECT?s in the past without any significant improvement. 5. Patients who were intellectually deficient. 6. Patients having schizoaffective disorder.

Design outcomes

Primary

MeasureTime frame
Improvement in score on the assessment scales namely Brief Psychiatric rating scale and Positive and negative syndrome scale for schizophrenia.Timepoint: Baseline After 4, 6 and at the end of ECT course.

Secondary

MeasureTime frame
Improvement in score on the Global assessment of functioning scale, Clinical global impressions and the World Health Organization Quality of life scale Brief version.Timepoint: Baseline and at the end of ECT course.

Countries

India

Contacts

Public ContactDr Rohit Garg

Department of Psychiatry, GMCH, Sector 32, Chandigarh

drchavanbs@yahoo.com9646121611

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026